Acquisition Opportunity Dependable Plastics was acquired by Biomerics in July 2022 to form the Biomerics Interventional Medical Plastics (IMP) Division, signaling a strategic alignment with medical device manufacturing. This presents cross-selling potential for plastic components and contract manufacturing services within Biomerics’ broader medical device ecosystem.

Medical Device Synergy The joining of Dependable Plastics with Biomerics emphasizes a focus on interventional medical plastics, suggesting opportunities to offer polymer processing, molding, and high-purity plastics solutions to medical device teams seeking vertically integrated supply and quality control.

Scale and Reach With revenue in the tens of millions and a modest employee base, there is room to upsell mid-to-large scale production capabilities, tooling, and rapid prototyping to expand production volumes within the Biomerics IMP Division and related medical device programs.

Digital/Tech Readiness Dependable Plastics uses common web and CMS technologies and showcases an online presence; leverage digital channels to initiate outreach, highlight capabilities in plastics manufacturing, compliance, and patient-safety driven processes to attract medical device customers seeking reliable contract partners.

Competitive Positioning In a market with players ranging from smaller specialized shops to larger plastics distributors, Dependable Plastics’ acquisition suggests a strategic path to differentiate via integrated medical plastics expertise, high-mix/low-volume agility, and collaboration with Biomerics’ device development pipeline.